| Cuproptosis: A novel therapeutic target for overcoming cancer drug resistance Y Wang, Y Chen, J Zhang, Y Yang, JS Fleishman, Y Wang, J Wang, ... Drug Resistance Updates 72, 101018, 2024 | 86 | 2024 |
| Targeting epigenetic and posttranslational modifications regulating ferroptosis for the treatment of diseases Y Wang, J Hu, S Wu, JS Fleishman, Y Li, Y Xu, W Zou, J Wang, Y Feng, ... Signal Transduction and Targeted Therapy 8 (1), 449, 2023 | 62 | 2023 |
| Bile acid metabolism and signaling in health and disease: molecular mechanisms and therapeutic targets JS Fleishman, S Kumar Signal Transduction and Targeted Therapy 9 (1), 97, 2024 | 50 | 2024 |
| Shedding light on non-alcoholic fatty liver disease: Pathogenesis, molecular mechanisms, models, and emerging therapeutics R Khairnar, MA Islam, J Fleishman, S Kumar Life Sciences 312, 121185, 2023 | 29 | 2023 |
| Pharmacological therapy of metabolic dysfunction-associated steatotic liver disease-driven hepatocellular carcinoma Y Wang, JS Fleishman, T Li, Y Li, Z Ren, J Chen, M Ding Frontiers in Pharmacology 14, 1336216, 2024 | 14 | 2024 |
| Epigenetic modification of ferroptosis by non-coding RNAs in cancer drug resistance H Wang, JS Fleishman, S Cheng, W Wang, F Wu, Y Wang, Y Wang Molecular Cancer 23 (1), 177, 2024 | 12 | 2024 |
| Targeting novel regulated cell death: Ferroptosis, pyroptosis, and autophagy in sepsis-associated encephalopathy J Sun, JS Fleishman, X Liu, H Wang, L Huo Biomedicine & Pharmacotherapy 174, 116453, 2024 | 11 | 2024 |
| The role of ABCC10/MRP7 in anti-cancer drug resistance and beyond DQ Chen, Y Xie, LQ Cao, JS Fleishman, Y Chen, T Wu, DH Yang Drug Resistance Updates, 101062, 2024 | 9 | 2024 |
| Hepatocellular Carcinoma and Lipid Metabolism: Novel Targets and Therapeutic Strategies LQ Cao, Y Xie, JS Fleishman, X Liu, ZS Chen Cancer Letters, 217061, 2024 | 8 | 2024 |
| Cell death in cancer chemotherapy using taxanes AP Xu, LB Xu, ER Smith, JS Fleishman, ZS Chen, XX Xu Frontiers in Pharmacology 14, 1338633, 2024 | 8 | 2024 |
| Targeting Anoikis Resistance as a Strategy for Cancer Therapy Y Wang, S Cheng, JS Fleishman, J Chen, H Tang, ZS Chen, W Chen, ... Drug Resistance Updates, 101099, 2024 | 7 | 2024 |
| Inducing ferroptosis by traditional medicines: a novel approach to reverse chemoresistance in lung cancer Y Wang, J Hu, JS Fleishman, Y Li, Z Ren, J Wang, Y Feng, J Chen, ... Frontiers in Pharmacology 15, 1290183, 2024 | 5 | 2024 |
| Pharmacologically inducing anoikis offers novel therapeutic opportunities in hepatocellular carcinoma Y Wang, JS Fleishman, J Wang, J Chen, L Zhao, M Ding Biomedicine & Pharmacotherapy 176, 116878, 2024 | 4 | 2024 |
| Tebentafusp: a novel drug for the treatment of metastatic uveal melanoma. Z Wang, Y Xie, JQ Wang, Y Cheng, J Fleishman, ZS Chen, Y Chen Drugs of Today (Barcelona, Spain: 1998) 59 (3), 179-193, 2023 | 4 | 2023 |
| Lipocalin-Type Prostaglandin D2 Synthase Protein- A Central Player in Metabolism MA Islam, R Khairnar, J Fleishman, K Thompson, S Kumar Pharmaceutical Research 39 (11), 2951-2963, 2022 | 4 | 2022 |
| New insights into the mechanism of resistance to lenvatinib and strategies for lenvatinib sensitization in hepatocellular carcinoma FM Fan, JS Fleishman, J Chen, ZS Chen, HH Dong Drug Discovery Today, 104069, 2024 | 2 | 2024 |
| NLRP3 Inflammasome Targeting Offers a Novel Therapeutic Paradigm for Sepsis-Induced Myocardial Injury Y Jin, JS Fleishman, Y Ma, X Jing, Q Guo, W Shang, H Wang Drug Design, Development and Therapy 19, 1025-1041, 2025 | | 2025 |
| cGAS-STING targeting offers novel therapeutic opportunities in neurological diseases H Wang, JS Fleishman, S Wu, G Wang, L Du, J Li, J Du Ageing Research Reviews, 102691, 2025 | | 2025 |
| cGAS-STING targeting offers therapy choice in lung diseases Y Wang, X Zhang, W Wang, Y Zhang, JS Fleishman, H Wang Biology Direct 20, 20, 2025 | | 2025 |
| Targeting ferroptosis offers therapy choice in sepsis-associated acute lung injury Y Wang, W Wang, Y Zhang, JS Fleishman, H Wang European Journal of Medicinal Chemistry 283, 117152, 2025 | | 2025 |
Zhe-Sheng ChenCollege of Pharmacy and Health Sciences, St. John's Universityبريد إلكتروني تم التحقق منه على stjohns.edu
